Galavit injection

SHARE WITH FRIENDS:

Galavit injection

📜 Basic information about the drug
Contents:
Pharmaceutical substance: aminodigidroftalazindion sodium (Galavit®) - 50 mg, 100 mg.

📝 Trade name of the drug: Galavit®

🧬 Pharmacological group:
immunomodulator and anti-inflammatory agent.

💉 Dosage form:
powder to prepare a solution for intramuscular injection.

🧪 Description: white or yellowish white crystalline powder.

👉 Application:
Immunomodulatory and anti-inflammatory agents in the complex treatment of immunodeficiency in adults and children from 12 years of age: gastric and duodenal ulcers; viral hepatitis; chronic recurrent diseases caused by herpes virus; diseases caused by human papilloma virus; infectious-inflammatory urogenital diseases (urethritis etiology in chlamydia and trichomoniasis, chlamydial prostatitis, acute and chronic salpingo-oophoritis, endometritis); purulent-inflammatory diseases of the small pelvic organs; postoperative rehabilitation of patients with uterine fibroids; in women of reproductive age in the postoperative period complications; postoperative purulent-septic complications and their prevention (including in oncological patients); chronic recurrent furunculosis, jaundice; asthenic conditions, neurotic and somatoform disorders, decreased physical performance (including in athletes), alcohol and drug dependence agi mental, behavioral and postabstinent disorders; inflammatory and infectious-allergic diseases of the central and peripheral nervous system; degenerative diseases of the nervous system; inflammatory diseases of the oral cavity and throat, periodontal disease.

In monotherapy in adults and children from 12 years of age: acute and chronic infectious-inflammatory diseases of the gastrointestinal tract with intoxication and / or diarrhea; in order to maintain clinical remission in the period between recurrences of chronic urogenital infections; when conducting immunorehabilitation activities.

Immunomodulators and anti-inflammatory agents in the complex treatment of immunodeficiency in children over 6 years of age: purulent surgical diseases (burns, chronic osteomyelitis, gangrenous appendicitis with omentitis, peritonitis, purulent pleurisy); Bacterial and ENT organs; recurrent diseases of viral etiology (frequent ARVI, bronchitis, pneumonia, chronic tonsillitis, chronic otitis, chronic adenoiditis).

Leave a comment